01 1Piramal Healthcare (Canada) Limited
01 1Deuruxolitinib Phosphate
01 1Blank
NDC Package Code : 55679-120
Start Marketing Date : 2025-06-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
51
PharmaCompass offers a list of Deuruxolitinib phosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Deuruxolitinib phosphate manufacturer or Deuruxolitinib phosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Deuruxolitinib phosphate manufacturer or Deuruxolitinib phosphate supplier.
PharmaCompass also assists you with knowing the Deuruxolitinib phosphate API Price utilized in the formulation of products. Deuruxolitinib phosphate API Price is not always fixed or binding as the Deuruxolitinib phosphate Price is obtained through a variety of data sources. The Deuruxolitinib phosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Deuruxolitinib phosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deuruxolitinib phosphate, including repackagers and relabelers. The FDA regulates Deuruxolitinib phosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deuruxolitinib phosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Deuruxolitinib phosphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Deuruxolitinib phosphate supplier is an individual or a company that provides Deuruxolitinib phosphate active pharmaceutical ingredient (API) or Deuruxolitinib phosphate finished formulations upon request. The Deuruxolitinib phosphate suppliers may include Deuruxolitinib phosphate API manufacturers, exporters, distributors and traders.
click here to find a list of Deuruxolitinib phosphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Deuruxolitinib phosphate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Deuruxolitinib phosphate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Deuruxolitinib phosphate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Deuruxolitinib phosphate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Deuruxolitinib phosphate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Deuruxolitinib phosphate suppliers with NDC on PharmaCompass.
